We simplify healthcare procurement

CRIZOTINIB 250MG CAPSULES - RIZONIB

SKU

MED01101

ALK-Positive Non-Small Cell Lung Cancer

Specs

Description

Crizotinib is used to treat a metastatic non-small cell lung cancer (NSCLC).

Additional Information

Side Effects	as configured:
Prescription Required	as configured:
Composition	Crizotinib as configured:
Comorbid Conditions	as configured:
Disease Coding \(ICD-10\)	as configured:
Therapeutic Indication	as configured:
Disease Biomarker	as configured:
Patient Population	as configured:
Disease Stage	as configured:
Disease Subtype	as configured:
Disease Name	as configured:
Disease Category	as configured:
Therapeutic Area	as configured:
Storage Class	as configured:
Clinical Trial Reference	as configured:
Approval Date	as configured:
Patient Leaflet \(PIL\) Link	as configured:
Pharmacological Class	as configured:
Pharmaceutical Category	as configured:
Additional Market and Clinical Insights	as configured:
All Brands Available \(Kenya & Globaly\)	as configured:
Local Regulatory Status	as configured:
Insurance Formulary Tags	as configured:
1st line, 2nd line, 3rd Line \(WHO, SHA, Private Insurance\)	as configured:
Hospital Level Tagging \(EML\)	as configured:
Dosage & Administration	as configured:
Most Demanded Strength & Formulation	as configured:
Most Prescribed in Class	as configured:
Indications	as configured:
Mechanism of Action	as configured:
Directions for Use	as configured:

Reviews

Only registered users can write reviews. Please, log in or register